Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Articles, Cellular/Molecular

Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons

Anibal Diogenes, Amol M. Patwardhan, Nathaniel A. Jeske, Nikita B. Ruparel, Vincent Goffin, Armen N. Akopian and Kenneth M. Hargreaves
Journal of Neuroscience 2 August 2006, 26 (31) 8126-8136; https://doi.org/10.1523/JNEUROSCI.0793-06.2006
Anibal Diogenes
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amol M. Patwardhan
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathaniel A. Jeske
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikita B. Ruparel
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Goffin
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Armen N. Akopian
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth M. Hargreaves
Departments of 1Pharmacology, 2Endodontics, and 3Cellular Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, and 4Université Paris Descartes, Faculté de Médecine, Le Site de l’Hôpital Necker, Institut National de la Santé et de la Recherche Médicale, Unité 808, F-75015 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Validation of cDNA microarray data. Selected genes from the Affymetrix experiment were further analyzed by real-time RT-PCR. Validated primers were used for each gene, and expression was normalized to the housekeeping gene 18S. Data are presented as mean ± SEM (n = 5 per group; **p < 0.01 and ***p < 0.001 vs respective vehicle control, two-tailed unpaired t test). N. Rec, Nuclear receptor subfamily 1, group D, member 1; 12-LOX, 12-lipoxygenase; IL 1-α, interleukin-1α; n.s., not significant.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Estrogen regulates PRL expression in TG neurons. A, Real-time RT-PCR experiments were performed with TG RNA samples from proestrous female rats and OVX female rats pretreated with either vehicle or estradiol (80 μg · kg−1 · d−1 for 10 d). Reactions were performed using primers specific for PRL gene and the internal control (18S). Data were normalized to the relative amount of OVX (vehicle) PRL mRNA/18S. Data are presented as mean ± SEM (n = 5 per group; **p < 0.01 vs PRL mRNA of the OVX/vehicle group, one-way ANOVA with Bonferroni’s post hoc test). B, Representative immunoblot of TG protein extracts. PRL was detected as a single band migrating at ∼25 kDa. Proteins were separated by 12.5% SDS-PAGE and probed with an antibody against PRL. Incubation of the antibody with the control peptide (20×) significantly blocked the immunoreactivity seen in TG protein samples from proestrous rats. C, Quantification of immunoblots of TG protein extracts from OVX rats injected with estradiol (2–80 μg/kg). Proteins were separated in 12.5% SDS-PAGE and probed with an antibody against PRL. Data are presented as mean ± SEM (n = 4 per group; *p < 0.05). D, Release of immunoreactive PRL from cultured TG neurons harvested from intact female rats. Data are presented as mean ± SEM percentage of basal release (n = 6 per group; *p < 0.05 and **p < 0.01, one-way ANOVA with Bonferroni’s post hoc test). E, Immunohistochemistry was performed to demonstrate colocalization of PRL with TRPV1 (horizontal arrows) in the proestrous rat TG. Vertical arrow shows a PRL-positive neuron that is not positive for TRPV1. F, The cell size distribution of the immunoreactive PRL-containing neurons. Approximately, of all PRL-positive cells, 50% were of small diameter (0–20 μm), 46.12% were of medium diameter (20–40 μm), and 3.7% were of large diameter (40–60 μm). The mean cell size was 21.4 μm (n = 1160). n.s., Not significant; Veh, vehicle.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    The expression of PRLR long form is regulated by estradiol. A, Representative immunoblot. Proteins were separated in a 12.5% SDS-PAGE and probed with an antibody against PRLR. The antibody recognized two bands migrating at ∼100 and 40 kDa, corresponding to the long and short PRLR isoforms, respectively. Blots were stripped and probed with an antibody against β-actin to normalize for loading differences. B, C, Quantification of immunoblots. TG proteins from OVX treated with E2 (0, 2, 20, or 80 μg/kg) were separated in a 12.5% SDS-PAGE and probed with an antibody against PRLR. Data are presented as mean ± SEM (n = 4 per group; *p < 0.05 and **p < 0.01, one-way ANOVA with Bonferroni’s post hoc test). U.OD., Uncalibrated OD; n.s., not significant; Veh, vehicle.    

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Prolactin augments capsaicin-evoked calcium influx in acutely cultured trigeminal ganglia neurons from intact female rats but not from OVX rats. A, Results of Ca2+ imaging experiments performed in acutely dissociated TG neurons. Data are presented as mean ± SEM percentage of vehicle (n = 30 per group; ***p < 0.001, two-way ANOVA). B, Representative traces of Ca2+ imaging experiments performed in neurons from proestrous rats. Neurons were treated with 40 nm PRL or vehicle for 10 min, followed by a 40 s capsaicin (30 nm) application. PRL did not evoke Ca2+ influx on its own but significantly potentiated capsaicin-evoked Ca2+ influx. Data are presented as mean ± SEM F340/F380 (n = 8 per group; error bars are SEM). C, Ca2+ imaging experiments performed in neurons from proestrous rats. Neurons were treated as described in the previous experiment (B). In addition, neurons were cotreated with PRL and the PRL receptor antagonist Δ1-9-G129R-hPRL (800 nm). The PRLR antagonist significantly blocked PRL potentiation of capsaicin-evoked Ca2+ influx, whereas it had no effect on its own. Data are presented as mean ± SEM percentage of vehicle (n = 19–40; *p < 0.05, two-way ANOVA). D, iCGRP release experiments were performed with TG neurons from intact female and OVX rats cultured for 5 d in the presence of E2 (50 nm) or vehicle. iCGRP was measured by radioimmunoassay. Data are presented as mean ± SEM percentage of vehicle (n = 4 per group; *p < 0.05 and **p < 0.01 vs iCGRP levels of each control group, two-tailed unpaired t test). Veh, Vehicle.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Prolactin sensitizes ICAP in TG neurons from naive, but not OVX, female rats. A, PRL concentration dependently sensitized ICAP with maximal potentiation observed at 4 nm (i.e., 0.1 μg/ml) with EC50 of 0.27 nm in cultured trigeminal neurons from naive female rats. Data are presented as mean ± SEM of PRL-treated ΔICAP (third ICAP − second ICAP) normalized to vehicle-treated ΔICAP (n = 8–12 per group; *p < 0.05 and ***p < 0.001, two-way ANOVA). B, PRL pretreatment increased capsaicin potency. Acutely dissociated TG neurons from female rats were pretreated with vehicle or PRL (40 nm) for 60 s, followed by a single capsaicin pulse (40 s, 0.1 nm to 5 μm). Data are shown as mean ± SEM (n = 12–20 per group; *p < 0.05 and ***p < 0.001 vehicle vs PRL, two-way ANOVA). C, D, Representative traces of ICAP recordings from intact (C) and OVX (D) female rat TG neurons. Concentration of applied CAP and PRL are indicated. CAP and PRL application durations were 30 and 60 s, respectively. EST, Estrogen treated; n.s., not significant.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Prolactin lowers the activation threshold temperature and potentiates heat-evoked inward currents in TG neurons from female rats. A, Pretreatment with PRL significantly decreased the threshold temperature for Iheat activation in cultured trigeminal neurons from naive female rats. Data are presented as mean ± SEM (n = 8–12 per group; ***p < 0.001 vs vehicle control, two-tailed unpaired t test). B, C, Pretreatment with PRL significantly potentiated inward currents evoked by 43°C (B) and 47°C (C). Data are presented as mean ± SEM (n = 8–12 per group; ***p < 0.001 vs vehicle control, two-tailed unpaired t test). D, E, Representative traces of Iheat recordings from TG neurons pretreated with PRL or vehicle. PRL lowered the activation temperature threshold and potentiated the magnitude of Iheat. Veh, Vehicle.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Prolactin induces the phosphorylation of TRPV1. A, Representative autoradiograph showing the incorporation of 32P in TRPV1 in acutely dissociated neurons from OVX and proestrous rats after treatment with PRL or vehicle. Proteins were separated in a 15% SDS-PAGE, and the immunoprecipitated TRPV1 was probed with a specific antibody. B, Quantification of 32P incorporation in TRPV1 from acutely cultured TG neurons from OVX and proestrous rats. Autoradiograph uncalibrated OD (U. OD.) was normalized by the TRPV1 U. OD. of each treatment group. PRL significantly induced TRPV1 phosphorylation in neurons from proestrous but, as observed in previous experiments, had no effect in neurons from OVX rats. Data are presented as mean ± SEM (n = 3 per group; *p < 0.05, two-tailed unpaired t test). Autorad, Autoradiography; WB, Western blot; n.s., not significant; Veh, vehicle; FEM, female.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Prolactin sensitizes female rats to capsaicin-evoked nocifensive behavior in an estrogen-dependent manner. A, Immunohistochemistry was performed in cornea cryosections from an intact female rat. The fixed cryosection was probed with antibodies against TRPV1 and PRLR. PRL receptors (green) are colocalized (white arrows) with TRPV1-containing fibers (red) innervating the cornea. B, Effect of pretreatment with PRL on capsaicin-induced eye wiping in proestrous rats. PRL (1 μg/μl in saline) or vehicle (40 μl) was applied in the eye, immediately followed by application of 0.01% capsaicin or vehicle (40 μl), and the total time spent grooming the injected eye per 5 min bins was measured by observers blinded to treatment allocation. Data are shown as mean ± SEM (n = 6 per group; *p < 0.05 and ***p < 0.001, two-way ANOVA). C, Effect of pretreatment with PRL on capsaicin-induced eye wiping in OVX rats treated with vehicle. The behavioral assay was conducted as described in B. Data are shown as mean ± SEM (n = 6 per group; two-way ANOVA). D, Effect of pretreatment with PRL on capsaicin-induced eye wiping in OVX rats treated with E2 (20 μg · kg−1 · d−1 for 10 d). The behavioral assay was conducted as described in B. Data are shown as mean ± SEM (n = 6 per group; **p < 0.01, two-way ANOVA). Veh, Vehicle.

Tables

  • Figures
    • View popup
    Table 1.

    Effect of estradiol administration (80 μg/kg for 10 d) versus vehicle on gene expression in trigeminal ganglia of ovariectomized rats as assessed by Affymetrix microarray

    Gene nameProbe set ID numberNCBI accession numberSAMaGSa
    Concordant increasers
        ProlactinE03166cds_s_at NM_012629 6.9≥1.5
        ProlactinV01244_at NM_012629 12.8≥1.5
        ProlactinV01250cds_s_at NM_012629 3≥1.5
        TrkA 3′ mRNA sequenceAA958274_at AA958274 1.5≥1.5
        Histidine ammonia lyaseAB002393_at NM_017159 1.5≥1.5
        Ania-10 early gene mRNA, 3′ UTRAF050662UTR#1_at NM_031593 1.6≥1.5
        Ania-12 early gene mRNA, 3′ UTRAF050664UTR#1_at XM_220080 1.5≥1.5
        Insulin receptor substrate 2 (IRS-2) mRNAAF087674_at XM_573948 1.4≥1.5
        Interleukin 1αD00403_g_at NM_017019 1.3≥1.5
        Aldosterone synthase, exon 9D14097cds_s_at NM_012537 1.5≥1.5
        Cytochrome P450, 3a18D38381_s_at NM_145782 1.3≥1.5
        Prepro bone inducing proteinD49494cds_s_at NM_024375 1.3≥1.5
        Nuclear receptor subfamily 1, group D, member 1M25804_g_at NM_145775 1.5≥1.5
        Cytochrome P450, 1a2M26127_s_at NM_012541 1.3≥1.5
        Interleukin 5 (colony-stimulating factor, eosinophil)X54419cds_at NM_021834 1.3≥1.5
        Cytosolic epoxide hydrolaseX60328_at NM_022936 1.7≥1.5
        Similar to Mus musculus pre 45S pre rRNA generc_AA859966_i_at AA859966 4.1≥1.5
        Cytochrome P450, subfamily IIC6rc_AA945571_s_at NM_001013904 1.7≥1.5
    Concordant decreasers
        Arachidonate 12-lipoxygenaseS69383_at NM_031010 0.5≤1.5
        Protein phosphatase 3, catalytic subunit, β isoformM31809_at NM_017042 0.6≤1.5
        Electron transf. flavoprotein (Etfa), mRNArc_AA894174_at NM_001009668 0.7≤1.5
    • ↵aAffymetrix microarray experiment was performed with TG RNA isolated from vehicle-treated or E2-treated (80 μg/kg for 10 d) rats (n = 5 per group). Results were individually analyzed by two independent methods: statistical analysis of microarrays (SAM) and GeneSpring 5.1 (GS). There were 18 genes found to be upregulated in both analyses (concordant increasers), and three genes were found to be downregulated in both analyses (concordant decreasers). Data are presented as means with false discovery rate of 10% for SAM and change cutoff for the GS. UTR, Untranslated region.

Back to top

In this issue

The Journal of Neuroscience: 26 (31)
Journal of Neuroscience
Vol. 26, Issue 31
2 Aug 2006
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons
Anibal Diogenes, Amol M. Patwardhan, Nathaniel A. Jeske, Nikita B. Ruparel, Vincent Goffin, Armen N. Akopian, Kenneth M. Hargreaves
Journal of Neuroscience 2 August 2006, 26 (31) 8126-8136; DOI: 10.1523/JNEUROSCI.0793-06.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Prolactin Modulates TRPV1 in Female Rat Trigeminal Sensory Neurons
Anibal Diogenes, Amol M. Patwardhan, Nathaniel A. Jeske, Nikita B. Ruparel, Vincent Goffin, Armen N. Akopian, Kenneth M. Hargreaves
Journal of Neuroscience 2 August 2006, 26 (31) 8126-8136; DOI: 10.1523/JNEUROSCI.0793-06.2006
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • prolactin
  • neuropeptide
  • prolactin receptor
  • antagonist
  • estradiol
  • estrogen
  • trigeminal
  • nociceptor
  • TRPV1
  • eye-wipe
  • capsaicin
  • heat
  • pain

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Neurophysiological Evidence for a Cortical Contribution to the Wakefulness-Related Drive to Breathe Explaining Hypocapnia-Resistant Ventilation in Humans
  • Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Show more Articles

Cellular/Molecular

  • CaMKIIβ-mediated phosphorylation enhances protein stability of spastin to promote neurite outgrowth
  • Bmal1 Modulates Striatal cAMP Signaling and Motor Learning
  • Activation of dopamine D1 receptors at the axon initial segment-like process of retinal AII amacrine cells modulates action potential firing
Show more Cellular/Molecular
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.